These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1136935)

  • 41. Steady-state serum quinidine concentration: role in prophylactic therapy following acute myocardial infarction.
    Halkin H; Vered Z; Millman P; Rabinowitz B; Neufeld HN
    Isr J Med Sci; 1979 Jul; 15(7):583-7. PubMed ID: 478822
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacodynamics of 3-hydroxyquinidine alone and in combination with quinidine in healthy persons.
    Vozeh S; Bindschedler M; Ha HR; Kaufmann G; Guentert TW; Follath F
    Am J Cardiol; 1987 Mar; 59(6):681-4. PubMed ID: 3825912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relation of ventricular premature beat suppression to serum quinidine concentraton determined by a new and specific assay.
    Carliner NH; Fisher ML; Crouthamel WG; Narang PK; Plotnick GD
    Am Heart J; 1980 Oct; 100(4):483-9. PubMed ID: 7415936
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of tocainide and quinidine on premature ventricular contractions.
    Wasenmiller JE; Aronow WS
    Clin Pharmacol Ther; 1980 Oct; 28(4):431-5. PubMed ID: 6773715
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacokinetics of quinidine sulfate in dairy cattle.
    Takemura N; Fujii T; Koyama H; Sako T; Suzuki K; Uchino T; Motoyoshi S
    Nihon Juigaku Zasshi; 1989 Jun; 51(3):515-20. PubMed ID: 2761143
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pharmacology and clinical biopharmacy of quinidine].
    Huynh-Ngoc T; Sirois G
    J Pharm Belg; 1974 Mar; 29(2):152-80. PubMed ID: 4840388
    [No Abstract]   [Full Text] [Related]  

  • 47. Quinidine for ventricular arrhythmias: value of electrophysiologic testing.
    DiMarco JP; Garan H; Ruskin JN
    Am J Cardiol; 1983 Jan; 51(1):90-5. PubMed ID: 6849270
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Comparison of the efficacy of aprindine and quinidine in chronic ventricular rhythm disorders].
    Leclercq JF; Attuel P; Milosevic D; Rosengarten MD; Coumel P
    Arch Mal Coeur Vaiss; 1981 Aug; 74(8):923-30. PubMed ID: 6793009
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Combination antiarrhythmic therapy for management of malignant ventricular arrhythmia.
    Patt MV; Grossbard CL; Graboys TB; Lown B
    Am J Cardiol; 1988 Nov; 62(14):18I-21I. PubMed ID: 2461071
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiarrhythmic therapy, ventricular premature depolarizations and sudden cardiac death: the tip of the iceberg.
    Cobb LA; Werner JA
    Circulation; 1979 May; 59(5):864-5. PubMed ID: 428097
    [No Abstract]   [Full Text] [Related]  

  • 51. Relationship between serum quinidine concentration and quinidine dosage.
    Allen NM
    Pharmacotherapy; 1992; 12(3):189-94. PubMed ID: 1608851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of acebutolol with propranolol, quinidine, and placebo: results of three multicenter arrhythmia trials.
    Chandraratna PA
    Am Heart J; 1985 May; 109(5 Pt 2):1198-204. PubMed ID: 3993535
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Ventricular arrhythmia incidence in the rat is reduced by naloxone.
    Pugsley MK; Hayes ES; Wang WQ; Walker MJ
    Pharmacol Res; 2015 Jul; 97():64-9. PubMed ID: 25920674
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Use of ajmaline in the therapy of various heart arrhythmias and comparison with the classic antiarrhythmic drug quinidine].
    Scardino R; Colao G; Didonato F; Sepe V
    Minerva Med; 1970 Sep; 61(78):4289-300. PubMed ID: 4930956
    [No Abstract]   [Full Text] [Related]  

  • 55. [On quinidine treatment].
    Sanna GP; Ventura L
    Cardiol Prat; 1970 Apr; 21(2):69-79. PubMed ID: 5494836
    [No Abstract]   [Full Text] [Related]  

  • 56. Control of paroxysmal atrial fibrillation recurrence using combined administration of propafenone and quinidine.
    Lau CP; Chow MS; Tse HF; Tang MO; Fan C
    Am J Cardiol; 2000 Dec; 86(12):1327-32. PubMed ID: 11113407
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effect of congestive heart failure on quinidine pharmacokinetics.
    Crouthamel WG
    Am Heart J; 1975 Sep; 90(3):335-9. PubMed ID: 1163425
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetic analysis of intravenously and orally administered quinidine in cows.
    McGuirk SM; Muir WW; Sams RA
    Am J Vet Res; 1981 Sep; 42(9):1482-7. PubMed ID: 7325456
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mexiletine in the treatment of resistant ventricular arrhythmias: enhancement of efficacy and reduction of dose-related side effects by combination with quinidine.
    Duff HJ; Roden D; Primm RK; Oates JA; Woosley RL
    Circulation; 1983 May; 67(5):1124-8. PubMed ID: 6831673
    [No Abstract]   [Full Text] [Related]  

  • 60. [The effect of quinidine monotherapy and combined therapy with digoxin on the central hemodynamics in patients with heart rhythm disorders].
    Orlov LL; Glezer MG; Tsintsadze GI; Zaĭchik IL
    Kardiologiia; 1992 Jul; 32(7-8):17-9. PubMed ID: 1487871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.